Investor mix
11 investors on record; lead investors include Early Stage Partners, ONSET Ventures, Capital Midwest Fund, Kaiser Permanente Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 91% |
| Private equity | 1 | 9% |
Cytopheresis systems for inflammatory conditions
11 investors on record; lead investors include Early Stage Partners, ONSET Ventures, Capital Midwest Fund, Kaiser Permanente Ventures.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 10 | 91% |
| Private equity | 1 | 9% |